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Abstract 
As a result of analysis of the available scientific data, a significant relationship 
between hyperkinetic syndromes and changes in the acid-base state has been revealed. The 
provoking effect of alkalosis on the occurrence and severity of hyperkinetic disorders was 
confirmed. An own example of effective treatment of patient with essential myoclonus with 
taking in account his acid-base state has been given. The addition of acetylsalicylic acid to the 
treatment with clonazepam caused a more significant decrease in the severity of hyperkinetic 
disorders and improved the patient’s general condition and his quality of life. So that we 
suggest studying of acid-base balance in patients with hyperkinetic syndromes and syndrome 
of increased neuromuscular excitability in the outpatient setting and in hospital conditions at 
the making of initial diagnosis, and also recommend studying of acid-base balance in patients 
who already have neurological diagnoses, if such a study has not been made previously. 
Correction of acid-base status in the treatment of patients with hyperkinetic syndromes and 
the syndrome of increased neuromuscular excitability contributes to greater effectiveness of 
therapy than just symptomatic treatment of hyperkinetic disorders. 
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ВОЗМОЖНОСТИ ПАТОГЕНЕТИЧЕСКОЙ КОРРЕКЦИИ 
ГИПЕРКИНЕТИЧЕСКИХ НАРУШЕНИЙ С УЧЕТОМ СОСТОЯНИЯ 
КИСЛОТНО-ОСНОВНОГО БАЛАНСА 
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Е. А. Колесник  
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В результате анализа имеющихся научных данных выявлена существенная 
взаимосвязь между гиперкинетическими синдромами и изменениями кислотно-
основного состояния. Подтверждено провоцирующее действие алкалоза на 
возникновение и выраженность гиперкинетических нарушений. Приведен собственный 
пример эффективного лечения пациента с эссенциальной миоклонус с учетом его 
кислотно-основного состояния. Авторы предлагают изучать кислотно-основного 
баланс у пациентов с гиперкинетическими синдромами и синдромом повышенной 
нервно-мышечной возбудимости в амбулаторных и в стационарных условиях при 
постановке первоначального диагноза, а также рекомендуют такого рода диагностику 
для пациентов, уже имеющих неврологические диагнозы. Коррекция кислотно-
основного состояния способствует большей эффективности терапии, чем просто 
симптоматическое лечение таких нарушений. 
Ключевые слова: кислотно-щелочной баланс, алкалоз, эссенциальный 
миоклонус, гиперкинетические расстройства 
 
Relevance of the topic. Hyperkinesias occupy a significant proportion of the 
neurological symptoms and syndromes that practicing neurologists reveal in their routine 
practice. One of these hyperkinesis is myoclonus. The term myoclonus is defined as sudden, 
rapid, shock-like movement. These movements can be “positive” or “negative”. Positive 
myoclonus leads to muscle contraction or muscle groups contaction. Asterixis or negative 
myoclonus is a short-term loss of muscle tone followed by contraction of other muscles, 
which leads to a nod type movement. These involuntary movements often have a 
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characteristic sawtooth pattern and they usually disappear during sleep. Typically, a 
myoclonus is a short (10–50 ms, rarely more than 100 ms), irregular muscle contractions, 
often without noticeable movement. Myoclonus amplitude can vary significantly. The 
lightning nature of a rectangular myoclonus wave helps in its differentiation from tremor 
(rhythmic oscillations), chorea (large, smooth movements), dystonia (reduction duration more 
than 100 ms, often with a twisting position), ticks (pulse duration> 100 ms, can be 
temporarily suppressed ), or fasciculations (single muscles involved, minimal motor effect [1, 
2]. 
Myoclonus can be physiological, familial, observed with progressive myoclonus 
epilepsy, lysosomal glycogen metabolism disorders, mitochondrial dysfunction, secondary 
due to congenital metabolic disturbances, injuries, neurodegenerative diseases, renal and 
hepatic insufficiency, non-ketone hyperglycemia and hypercapnia, alkalosis, alkalosis, 
alkalosis, alkalosis, alkalosis, alkalosis, alkalosis [3-6]. 
The stabilization of the acid-base state of the human body is provided by phosphate 
(1% of the buffer capacity of blood, its role in the tissues, especially in the kidneys, is very 
significant), bicarbonate (10% of the buffer capacity of blood), protein and hemoglobin (about 
70% of the buffer blood capacity) buffer systems and the functioning of specific physiological 
mechanisms of compensation in some organs (lungs, kidneys, liver, gastrointestinal tract, 
bone tissue) [7-9]. 
Phosphate buffer system provides regulation of acid-base balance within cells, mainly 
kidney tubules. Phosphate buffer consists of two components: - Na2HPO4 (alkali) and 
NaH2PO4 (acid). 
Bicarbonate buffer system is a buffer of blood and intercellular fluid, it maintains the 
balance of HCO3 / CO2. Where: 
 
 H + HCO3 <----> H2CO3 <----> CO2 + H2O 
 
HCO3 functions as a base. CO2 (carbon dioxide) - as an acidic substance. Thus, an 
increase in HCO3 (bicarbonate) or a decrease in CO2 will make the blood more alkaline. 
Reducing HCO3 or increasing CO2 makes the environment more acidic. CO2 levels are 
physiologically regulated by the pulmonary system through respiration, while HCO3 levels 
are regulated by the kidneys through reabsorption. Thus, respiratory alkalosis is a decrease in 
the CO2 content in serum. Although it is theoretically possible to reduce the production of 
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CO2, this condition is mainly the result of hyperventilation, when CO2 is exhaled through the 
lungs [10]. 
Protein buffer system - the main intracellular buffer. It accounts for about 75% of the 
buffer capacity of the intracellular fluid. The components of the protein buffer are an acid 
weakly dissociating protein (protein COOH) and salts of a strong base (protein COONa). 
Hemoglobin buffer system is the most capacious blood buffer. It consists of the acidic 
component - oxygenated HbO2 and alkaline - non-oxygenated Hb. 
Bone carbonates are a depot for buffer systems of the whole body. They contain 
deposited a significant amount of salts of carbonic acid. With a rapid increase in the acid 
content, this system provides up to 30-40% of the buffer capacity. 
Changes in the acid-base state are possible both in the direction of alkalosis and in the 
direction of acidosis. At the same time, as a rule, more attention is paid to the development of 
acidosis in the pathogenesis of diseases, including neurological ones, although both of these 
conditions have a negative effect on the functional state of the nervous system. 
Alkalosis might be compensated and uncompensated. With compensated alkalosis, the 
indicators of the acid-base status of the blood are within the normal range and only changes in 
buffer systems and regulatory mechanisms are observed. With uncompensated alkalosis, the 
pH exceeds the upper limit of normal, which is caused by an excess of bases and a violation 
of the physiological mechanisms of regulation of acid-base balance. 
The main causes of metabolic alkalosis are listed below [11]: 
Chloride depletion: 
gastric diseases: vomiting, mechanical drainage, bulimia 
chloruretic diuretics: bumetanide, chlorothiazide, metalazone, etc. 
diarrhea: villous adenoma, congenital chloride diarrhea, posthypercapnic state 
reduction of chlorides in food with a base load: chloride-deficient infant formula 
gastrocystoplasty 
cystic fibrosis (cystic fibrosis) - a high content of chloride in sweat 
excess potassium / excess mineralocorticoid 
primary aldosteronism: adenoma, idiopathic, hyperplasia, renin-sensitive, 
glucocorticoid-suppressed, carcinoma 
mineralocorticoid excess 
primary excess of deoxycorticosterone: deficiency of 11β- and 17α-hydroxylase 
drugs: licorice (glycyrrhizic acid) in the form of confectionery or flavoring, 
carbenoxolone 
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Liddle syndrome 
secondary aldosteronism 
excess adrenal corticosteroids: primary, secondary, exogenous 
severe hypertension: malignant, accelerated, renovascular 
hemangiopericytoma, nephroblastoma, renal cell carcinoma 
Bartter syndrome and Gitelman syndrome and their variants 
laxative abuse, clay consumption 
Hypercalcemic condition 
hypercalcemia in malignant tumors 
acute or chronic milk alkaline syndrome 
Other 
carbenicillin, ampicillin, penicillin 
bicarbonate intake: massive or in the presence of renal failure 
way out of starvation 
hypoalbuminemia 
Acid-alkaline imbalance in various metabolic disorders naturally leads to disruption of 
the functioning of the brain and spinal cord. Compared with acidosis, patients with alkalosis 
have more severe neurological symptoms that are difficult to correct [12-16]. This is due, in 
particular, to the greater sensitivity of GABA-ergic neurons to alkalosis than to acidosis [12]. 
Alkalosis can provoke the development of many neurological symptoms, in particular, 
myoclonus. With a sharp change in pH above 7.55, a significant decrease in cerebral blood 
flow is observed with the development of seizures and coma [17]. 
Photo-myoclonus and myoclonus-like hyperkinesis have been described in metabolic 
alkalosis [18, 19]. 
In 2003, the first case of myoclonus caused by metabolic alkalosis due to vomiting 
associated with drug intake was described, in which severe hyponatremia, bipocalemia and 
alkalosis were also observed [20]. A case of metabolic alkalosis and myoclonus caused by the 
use of antacids containing sodium bicarbonate in a person with a pre-existing cerebrovascular 
disease was described in Japan [21]. Also described is the case of the occurrence of 
myoclonus in a 90-year-old patient on the background of long-term use of licorice contained 
in the antacid preparation [22] 
Neuromuscular symptoms of metabolic alkalosis include, in addition to myocloni, also 
paresthesias and fasciculations, which may be associated with a decrease in the content of 
ionized calcium in serum. At the same time, Chvostek’s symptom is usually negative. 
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Fasciculations and tetany are generally more common than myoclonus. It is assumed that 
tetany is caused not only by a decrease in the concentration of ionized calcium in serum, but 
is also associated with an increase in pH-dependent myofibrillary sensitivity to calcium [23, 
24]. 
In addition to metabolic alkalosis, respiratory alkalosis is also isolated. It is the most 
common acid-base imbalance, with the same frequency occurring in men and women. The 
frequency and prevalence of the disease depends on the etiology. Accordingly, the level of 
morbidity and mortality also depends on the etiology of the disease. In almost all cases, 
respiratory alkalosis is induced by hyperventilation, leading to central mechanisms, 
hypoxemia, pulmonary pathology and iatrogeny [10]. The central causes are head injuries, 
strokes, hyperthyroidism, anxiety disorders, pain, stress, the effects of certain drugs, drugs 
such as salicylates and various intoxications [10]. Hypoxic stimulation leads to 
hyperventilation in an attempt to correct hypoxia due to the loss of CO2. Pulmonary causes 
include pulmonary emboli, pneumothorax, pneumonia, and acute asthma or COPD 
exacerbations. Iatrogenic causes are primarily associated with hyperventilation in intubated 
patients with mechanical ventilation [10]. 
There are the following pathogenetic aspects of the development of respiratory 
alkalosis in various somatic diseases [25]: 
Hyperthyroidism: hyperthyroidism increases the severity of ventilation chemoreflexes, 
thereby causing hyperventilation. The severity of chemoreflexes normalized in the treatment 
of hyperthyroidism. 
Pregnancy: Progesterone levels increase during pregnancy. Progesterone stimulates 
the respiratory center, which can lead to respiratory alkalosis, which is common in pregnant 
women. [26]. 
Congestive heart failure: in patients with congestive heart failure (and other diseases 
with a decrease in cardiac output) hyperventilation is observed at rest, during exercise and 
during sleep. This is due to the fact that pulmonary vascular and interstitial receptors are 
stimulated due to pulmonary stagnation. In addition, low cardiac output and hypotension 
stimulate respiration by acting on the arterial baroreceptors. 
Chronic / severe liver disease. Several mechanisms have been proposed to explain 
hyperventilation associated with liver disease. Elevated levels of progesterone, ammonia, 
vasoactive intestinal peptide and glutamine can stimulate respiration. Patients with severe 
liver disease or portal hypertension may have pulmonary arteriovenous anastomoses in the 
lungs or portal pulmonary shunts, leading to hypoxemia. This stimulates peripheral 
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chemoreceptors and leads to hyperventilation, and the degree of respiratory alkalosis 
correlates with the severity of liver failure. [26] 
Salicylate overdose: Respiratory alkalosis initially develops, followed by metabolic 
acidosis, which causes secondary hyperventilation. 
Fever and sepsis: Fever and sepsis can manifest as hyperventilation, even before the 
development of hypotension. The exact pathogenetic mechanism of this condition is 
unknown, but it is believed that it is due to the stimulation of the carotid sinus or 
hypothalamus with increasing body temperature. 
Gram-negative sepsis: before the development of fever, hypoxia or hypotension, acute 
respiratory alkalosis develops, which may be the only early symptom. [26]. 
Pain: Hyperventilation can be caused by stimulation of peripheral and central 
chemoreceptors, as well as behavior control systems. 
Hyperventilation syndrome, which is also known as psychogenic hyperventilation, 
was first described in 1935 [27]. Hyperventilation is triggered by stress and anxiety, both of 
which act on the behavioral control of breathing. Hyperventilation stops during sleep, when 
the behavioral control system is inactive, and only the metabolic system controls respirat ion. 
The diagnosis of hyperventilation syndrome is a diagnosis of exclusion, it is necessary to 
exclude all organic diseases, including, above all, life-threatening conditions, such as: 
pulmonary embolism, myocardial ischemia, hyperthyroidism, before making this diagnosis 
[28]. 
Respiratory alkalosis, in turn, can be acute and chronic. This is determined based on 
the level of metabolic compensation for respiratory disease. Excessive levels of HCO3 are 
buffered to maintain physiological pH through renal reduction of H secretion and increased 
secretion of HCO3, however, this metabolic process takes several days, while respiratory 
disease can alter CO2 levels in minutes or hours. Thus, acute respiratory alkalosis is 
associated with high bicarbonate levels, since there was not enough time to reduce HCO3 
levels, and chronic respiratory alkalosis was associated with low and normal HCO3 levels 
[10]. 
The symptoms of respiratory alkalosis depend on its duration, severity and underlying 
disease causing hyperventilation. Hyperventilation syndrome can mimic many other serious 
diseases and includes weakness, cardiac arrhythmias, increased neuromuscular excitability, 
tingling in the fingers and toes and around the lips (paresthesia), chest pain, with pronounced 
alkalosis, tetany can develop [29, 30]. Acute onset of hypocapnia can cause cerebral 
vasoconstriction with a decrease in cerebral blood flow and such neurological symptoms as 
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dizziness, confusion, syncope and convulsions. The first cases of spontaneous 
hyperventilation with the development of dizziness and tingling, followed by the development 
of tetany, were described in 1922 in patients with cholecystitis, abdominal distension and 
hysteria. [31]. Haldane JS, Poulton EP. (1908) described painful tingling in the hands and 
feet, numbness and sweating of the hands, and cerebral symptoms that occurred after 
experimental hyperventilation. [32]. 
Treatment of respiratory alkalosis is aimed at treating the underlying pathology. In 
patients with anxiety disorders, anxiolytics are used. Beta-adrenergic blockers can help 
control sympathicotonia, which can lead to hyperventilation syndrome in some patients. [28]. 
Determining the presence of sympathicotonia in the cardiovascular system in clinical practice 
is most appropriate, from our point of view, using the Kerdo index or cardiointervalometry. 
Treatment of respiratory alkalosis primarily depends on the cause of it. Antibiotics are 
effective for infectious diseases. For embolic diseases, anticoagulant therapy is necessary. 
Support for lung ventilation may be required in patients with acute respiratory failure, asthma, 
acute or chronic obstructive pulmonary disease. In patients who are on artificial ventilation, it 
may be necessary to regulate the ventilation parameters with a decrease in the respiratory rate. 
In this group of patients, it is also necessary to control the content of arterial and venous 
gases. In severe cases, the pH can be directly restored using acidifying agents [10]. 
Generally accepted in clinical practice is the provision of the mandatory control of 
acid-base balance in intensive care units and intensive care units. In other cases, much less 
attention is paid to the study of acid-base balance, which primarily applies to outpatient 
patients, in particular, to patients with a neurological profile. This situation is explained in 
particular by the fact that the indicators of acid-base balance are in fairly tight boundaries and 
their significant changes in most cases cause serious violations of the patient’s health, leading 
to their hospitalization in the intensive care unit and intensive care unit. It has been 
established that with metabolic alkalosis with pH 7.55, the risk of death is 45%, with 
indicators above 7.65 the risk increases significantly and reaches 80% [33,34]. 
The results of our own observations: Under our observation was the patient, who 
was sent to us for a consultation with myoclonic hyperkineses. In the study of indicators of 
acid-base status of the blood, a pronounced alkalosis with a pH of 7.75 was detected. In 
connection with the naturally arising doubts about the reliability of the analysis, a repeated 
study was performed. With repeated analysis, the pH was at the level of 7.65. 
Data from laboratory and instrumental methods of research of a patient: 
TSH - 1.24 µMO / ml 
 166 
Free thyroxin T4 - 1,5ng / dl 
Triiodothyronine free T3 - 4.26 pg / ml 
Antibodies to thyroglobulin less than 10 MO / ml 
Antibodies to thyroperoxidase - 0.66 IU / ml 
Tireoglobulin - 20,4 ng / ml 
Parathyroid hormone - 41 pg / ml 
Calcitonin - less than 2 pg / ml 
Potassium - 4.25 mmol / l 
Sodium - 144.0 mmol / l 
Calcium ionized - 1.16 mmmol / l 
Bicarbonate - 30.6 mmol / l, the norm - 22.0 - 29.0 mmol / l 
Ceruloplasmin venous blood - 0.369 g / l 
The blood pH 06.14.18 - 7.75, 06.30.18 - 7.605, 10.17.18 - 7.42. 
РСО2 - 51.6 mmHg, PO2 - 22 mmHg. 
Urine: straw yellow, clear, specific gravity 1014, pH - 6.0, protein - no, glucose - no 
Leukocytes - 2-3 in the field of view, epithelium flat 1-2 in the field of view. 
MRI of the brain: MR signs of moderate expansion of convective cerebrospinal fluid 
spaces in the frontal regions, uneven expansion of perivascular spaces. Volume and focal 
formations of the brain was not detected. EEG showed no signs of epileptic activity. 
The fundus of the eye: the optic nerve discs are pale pink, clear boundaries, narrowed 
arteries, dilated veins. Diagnosis: OI Angiopathy of the retina. 
Myoclonic hyperkinesis was observed in neurological status. Meningeal and focal 
signs were not found. Chvostek’s and Trousseau’s signs were absent. For the purpose of 
differential diagnosis between metabolic and gas alkalosis, a study was made to determine the 
content of bicarbonate levels in blood serum, the level of which, as is known, increases with 
metabolic alkalosis. An increase in serum bicarbonate levels above normal was found, 
indicating metabolic alkalosis. The content of ionized calcium in the patient’s blood was 
within the normal range. Serum potassium and magnesium levels were also within the normal 
range, which made it possible to exclude the presence of Bartter and Gitelman syndrome. 
In order to conduct pathogenetic and symptomatic therapy, the patient was prescribed 
acetylsalicylic acid at a dosage of 75 mg 1 time per day and clonazepam at the standard 
dosage, which led to a pH shift to 7.45 after 1 month and a significant reduction in the 
severity of myoclonic hyperkineses. 
Conclusions: 
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1. As a result of our analysis of the available scientific data, a significant relationship 
has been revealed between hyperkinetic syndromes and changes in the acid-base state. 
2. The provoking effect of alkalosis on the occurrence and severity of hyperkinetic 
disorders was revealed. 
3. In connection with the above, we consider it expedient to study acid-base balance in 
patients with hyperkinetic syndromes and syndrome of increased neuromuscular excitability 
in the outpatient setting and in hospital conditions at the initial diagnosis, and we also 
recommend the study of indicators of acid-base balance in patients with hyperkinetic 
syndromes and syndrome of increased neuromuscular excitability, already having 
neurological diagnoses, if such a study has not been performed previously. 
4. Correction of the acid-base state in the treatment of patients with hyperkinetic 
syndromes and the syndrome of increased neuromuscular excitability contributes to a greater 
effectiveness of the therapy given than the symptomatic treatment of hyperkineses only. 
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